share_log

HC Wainwright & Co. Reiterates Buy on Mirum Pharmaceuticals, Maintains $58 Price Target

HC Wainwright & Co. Reiterates Buy on Mirum Pharmaceuticals, Maintains $58 Price Target

HC Wainwright & Co.重申買入Mirum Pharmicals,維持58美元的目標股價
Benzinga ·  05/09 06:38

HC Wainwright & Co. analyst Ed Arce reiterates Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and maintains $58 price target.

HC Wainwright & Co. 分析師埃德·阿爾塞重申米魯姆製藥公司(納斯達克股票代碼:MIRM)的買入並維持58美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論